Voleon Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Voleon Capital Management's AMRX Position: Q3 2026 in Review
Voleon Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 4.4% in Q3 2026, selling an estimated $389K and leaving 464,452 shares worth $9.35M. The position accounts for 0.17% of the portfolio, ranked #129.
Voleon Capital Management first reported a position in AMRX in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.8M in Q4 2025. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Voleon Capital Management held 464,452 shares of Amneal Pharmaceuticals worth $9.35M as of Q3 2026.
- Voleon Capital Management sold 21,600 Amneal Pharmaceuticals shares in Q3 2026, an estimated $389K.
- Amneal Pharmaceuticals made up 0.17% of Voleon Capital Management's portfolio in Q3 2026, its #129 holding.
- Voleon Capital Management first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- Voleon Capital Management's Amneal Pharmaceuticals position peaked at $10.8M in Q4 2025.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.